(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

K-HALER

Essa marca aparece no histórico oficial do USPTO.

Mesmo quando o status está encerrado, o histórico ajuda a calibrar o risco, evitar repetição de erros e definir uma estratégia segura de naming.

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILEDTipo: VerbalEscritório: US

Snapshot rápido

K-HALER

ST13

US500000079096733

Classe

5, 10, 16

Pedido

79096733

Registro

4251980

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Histórico relevante

Situação USPTO

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED

Tipo de processo

Pedido e registro

Eventos registrados

49

Atualização mais recente

06/08/2026

Classificação

Inactive

Tipo de marca

Verbal

Classes Nice

5, 10, 16

Data de depósito

29/03/2011

Data de registro

04/12/2012

Data de expiração

-

Ação recomendada

Use este histórico como insumo para naming, mas confirme disponibilidade atual em todas as classes relevantes.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

11/01/2026

Última transação

06/08/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

404

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

Cambridge, CB4 0AB, GB

Examinador

RICHARDS, SUSAN

Unidade examinadora

L30

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Clinical Designs Limited

Representantes

Michelle L. Visser Rader, Fishman & Grauer PLLC

Classificação técnica

Classes Nice

Classe 5Classe 10Classe 16

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical preparations for the treatment of respiratory diseases and disordersasthmachronic obstructive pulmonary disease (COPD)emphysemadiabetes and human immunodeficiency virus (HIV); pharmaceutical preparations for use in pulmonary delivery systems in the nature of inhalers for the treatment of respiratory diseases and disordersasthmachronic obstructive pulmonary disease (COPD)emphysemadiabetes and human immunodeficiency virus (HIV); inhalers filled with pharmaceutical preparations for the treatment of respiratory diseases and disordersasthmachronic obstructive pulmonary disease (COPD)emphysemadiabetes and human immunodeficiency virus (HIV); drug delivery agents in the form of inhalants that release the active ingredients for a wide range of pharmaceuticals; pharmaceutical preparations for use in inhalersinhalation apparatusdevices and dispensersdrug delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceuticals

Classe 10

Medical devicesnebulizers for respiration therapy; aerosol dispensers for medical use; inhalers for medical purposes sold empty and inhalers for therapeutic use sold empty; metered dose inhalers for therapeutic use sold empty; nebulizers for administering medication in the form of a mist inhaled into the lungs for treatment of respiratory diseases; and parts and fittings for all the aforesaid goods

Classe 16

Printed matterbookletsmanualsmagazinesbooksguidespamphletscataloguesjournalsnewslettersseries of written articlesreportsprinted press releasespromotional literature and product guides in the fields of respiratory diseases and disordersdiabetes and human immunodeficiency virus (HIV); packing paper and cardboard for pharmaceutical packaging; printed patient record cards and prescription pads; pharmaceutical information leaflets; books in the fields of medicine and pharmaceuticals; printed publicationsmagazinesnewsletterspamphletsreportsinstructional and informational leafletspostersin the fields of medicine and pharmaceuticals; packing paper; stationery; printed instructional and teaching materials in the fields of pharmaceuticalshealth care and medicine relating to the pharmaceuticalhealth care and medical fields

Publicações

Histórico de despachos e eventos da marca no USPTO.

49 publicações encontradas

DENA

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED

06/08/2026

DETH

DEATH OF INTERNATIONAL REGISTRATION

06/08/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

22/01/2023

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

19/06/2020

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

21/05/2020

INPC

INVALIDATION PROCESSED

21/05/2020

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

05/03/2020

NREP

NEW REPRESENTATIVE AT IB RECEIVED

15/08/2019

C71T

CANCELLED SECTION 71

05/07/2019

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

04/12/2017

RNWL

INTERNATIONAL REGISTRATION RENEWED

19/05/2016

NREP

NEW REPRESENTATIVE AT IB RECEIVED

13/02/2015

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

30/03/2013

FICS

FINAL DISPOSITION NOTICE SENT TO IB

08/03/2013

FIMP

FINAL DISPOSITION PROCESSED

08/03/2013

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

04/03/2013

R.PR

REGISTERED-PRINCIPAL REGISTER

04/12/2012

GPNX

NOTIFICATION PROCESSED BY IB

13/10/2012

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

18/09/2012

PUBO

PUBLISHED FOR OPPOSITION

18/09/2012

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

29/08/2012

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

29/08/2012

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

29/08/2012

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

14/08/2012

EXPT

EXPARTE APPEAL TERMINATED

06/08/2012

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/08/2012

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

31/07/2012

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

31/07/2012

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

26/07/2012

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

26/07/2012

ALIE

ASSIGNED TO LIE

23/07/2012

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

19/07/2012

EXPI

EX PARTE APPEAL-INSTITUTED

19/07/2012

JURT

JURISDICTION RESTORED TO EXAMINING ATTORNEY

19/07/2012

EXAF

EXPARTE APPEAL RECEIVED AT TTAB

19/07/2012

CNFR

FINAL REFUSAL MAILED

20/01/2012

CNFR

FINAL REFUSAL WRITTEN

20/01/2012

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

28/12/2011

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

27/12/2011

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

27/12/2011

RFNT

REFUSAL PROCESSED BY IB

20/07/2011

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

27/06/2011

RFRR

REFUSAL PROCESSED BY MPU

27/06/2011

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

27/06/2011

CNRT

NON-FINAL ACTION WRITTEN

26/06/2011

DOCK

ASSIGNED TO EXAMINER

25/06/2011

MAFR

APPLICATION FILING RECEIPT MAILED

24/05/2011

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

20/05/2011

SDRC

SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

19/05/2011

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace K-HALER ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.